Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19 and primary wound healing: A new insights and advance. | Int Wound J | 2023 | 37488776 | PubTator, text mining | PubMed |
| Vector-delivered artificial miRNA effectively inhibits Porcine epidemic diarrhea virus replication. | Virol J | 2023 | 37488599 | PubTator, text mining | PubMed |
| Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis. | JMIR Bioinform Biotechnol | 2023 | 37485046 | PubTator, text mining | PubMed |
| HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B. | PLoS Pathog | 2023 | 37459363 | PubTator, text mining | PubMed |
| Investigation of SARS-CoV-2 Detection Method Applicability and Virus Occurrence in Food and Food Packaging. | Food Technol Biotechnol | 2023 | 37457910 | PubTator, text mining | PubMed |
| Genomic Insights Into the Evolution and Demographic History of the SARS-CoV-2 Omicron Variant: Population Genomics Approach. | JMIR Bioinform Biotechnol | 2023 | 37456139 | PubTator, text mining | PubMed |
| Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19. | Int J Mol Sci | 2023 | 37445984 | PubTator, text mining | PubMed |
| The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients. | J Clin Med | 2023 | 37445405 | PubTator, text mining | PubMed |
| Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles. | Int J Vet Sci Med | 2023 | 37441062 | PubTator, text mining | PubMed |
| Identification of a syncytin gene in a non-rodent laboratory mammal, Suncus murinus. | J Vet Med Sci | 2023 | 37438116 | PubTator, text mining | PubMed |
| Bidirectional interplay between SARS-CoV-2 and autophagy. | mBio | 2023 | 37436071 | PubTator, text mining | PubMed |
| Automated System for Multiplexing Detection of COVID-19 and Other Respiratory Pathogens. | IEEE J Transl Eng Health Med | 2023 | 37435542 | PubTator, text mining | PubMed |
| YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection. | BMC Med Genomics | 2023 | 37430323 | PubTator, text mining | PubMed |
| Identification, Isolation, and Molecular Characterization of Betacoronavirus in Oryx leucoryx. | Microbiol Spectr | 2023 | 37428095 | PubTator, text mining | PubMed |
| Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2. | Virol J | 2023 | 37422646 | PubTator, text mining | PubMed |
| Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). | Int J Oncol | 2023 | 37417358 | PubTator, text mining | PubMed |
| Identification of common genetic characteristics of rheumatoid arthritis and major depressive disorder by bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37415981 | PubTator, text mining | PubMed |
| Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach. | Res Sq | 2023 | 37398361 | PubTator, text mining | PubMed |
| Molecular mimicry and autoimmunity in the time of COVID-19. | J Autoimmun | 2023 | 37390745 | PubTator, text mining | PubMed |
| Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data. | Epidemics | 2023 | 37379776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=19